Please note that insurers have not changed their policy regarding orthopedic autologous bone marrow cell treatments as they are still considered experimental. Orthopedic autologous bone marrow cell treatments are an innovative option to bypass the need for a total joint replacement but there are several options we can use to postpone or prevent that need. Insurance will be filed for any claimable treatment, office visit, or procedure.